AZAD continually invests into further development and expansion of its API portfolios. Process research on new APIs is performed under the supervision of AZAD’s chemists based in Switzerland, at our R&D labs in Armenia, allowing cost-effective development of innovative chemistry and polymorphic forms of APIs, that are then patent-protected. In addition, using the above facility and expertise, AZAD offers contract R&D for 3rd parties interested in synthetic route development of specific APIs.
|Ferric Carboxymaltose||Iron deficiency||Produced in Switzerland|
|Tafamidis||ATTR-Amyloidose (CM and PN)||New polymorph; produced in Switzerland|